Diseases of the Endocannabinoid SystemSpringer Nature, 15 avr. 2025 - 147 pages This book fills the need for a detailed examination of the role of Endocannabinoid System in all the body's main organ systems and how dysregulation of that system can lead to disease. It serves as an in-depth analysis of the thousands and thousands of studies on the Endocannabinoid System within the medical literature. It covers the many diseases that can result from Endocannabinoid system dysfunction, ranging from metabolic syndrome to anxiety disorders to osteoporosis.
The book is written primarily for medical providers and those with a science background. |
Table des matières
| 1 | |
| 6 | |
The Gi Tract | 11 |
Metabolism | 23 |
Cardiovascular System | 33 |
Respiratory System | 44 |
Kidney and Urinary System | 51 |
Musculoskeletal and Connective Tissues | 59 |
Peripheral Nervous System and Spinal Cord | 75 |
Central Nervous System Pain Movement and Memory | 85 |
Central Nervous System Sleep Cognition and Neuroprotection | 96 |
Mood Motivation and Mental Health | 109 |
Reproduction Embryogenesis and Development | 123 |
The Eye | 132 |
Cell Death and Cancer | 137 |
| 142 | |
Autres éditions - Tout afficher
Diseases of the Endocannabinoid System Jean-Paul Henri Dedam,Fogel Elizabeth,Fogel Matthew Aucun aperçu disponible - 2025 |
Expressions et termes fréquents
2-arachidonoylglycerol Activation of CB1 acute AEA levels agonist amygdala anandamide anxiety apoptosis associated Biol blockage blood pressure brain cancer cannabinoid CB1 cannabinoid CB2 receptor cannabinoid receptor cannabis users CB1 activation CB1 and CB2 CB1 knockout mice CB1 receptor CB1 receptor activation chronic Clin CNR1 cortex cyclic vomiting syndrome cytokines decreased depression disease dorsal dronabinol ECS tone endocannabinoid system enzyme Epub expression FAAH function GABA GABAergic gene ghrelin glutamatergic Hemopressin hormone https://doi human hypertension hypothalamus immune cells immune system increased induced inflammation inflammatory inhibition inhibitor insulin kidney knockout mice license to Springer Marzo mechanism mediated medical cannabis metabolic models modulation nerve neurons neuropathy Neurosci nucleus obesity opiate pain pathway patients peripheral Pharmacol Physiol Piomelli PMID polymorphism potential PPAR produce rats reduced regulation release renal response rimonabant risk role serotonin shown sleep spinal cord stress symptoms syndrome tion tissues TRPV1 Wang